Drug
Zyil1
Zyil1: highest development phase Phase 2, developed by Zydus. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zydus
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZYIL1 capsule NCT05186051 | Phase 2 | Cryopyrin Associated Periodic Syndrome |
| ZYIL1 capsule NCT04731324 | Phase 1 | Healthy |
Latest
No recent events.
Follow Zyil1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.